SADA PRIT
Live / Registered — Registered (as of 06 Jan 2026)
What this means for you
Registered since 06 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79420192
- Registration number
- 8090719
- Mark type
- Stylized text
- Filed
- 04 Feb 2025
- Published for opposition
- 18 Nov 2025
- Registered
- 06 Jan 2026
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer
- Class 042 — Scientific and technological services: Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis in the field of the production of antibodies; scientific and technology services, namely, scientific research, testing and analysis in the field of antibodies and research and design services related thereto; industrial analysis services and industrial research services in the field of antibodies; industrial analysis and industrial research services in the field of chemistry
Owner
- Y-mAbs Therapeutics, Inc, NY, US
- Y-mAbs Therapeutics, Inc, NY, US
- Y-mAbs Therapeutics, Inc, NY, US
Prosecution history
- 10 Sept 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 26 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 26 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 06 Aug 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 16 Jul 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 16 Jul 2026 — FINAL DISPOSITION PROCESSED
- 06 Apr 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 06 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 20 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Nov 2025 — PUBLISHED FOR OPPOSITION
- 15 Nov 2025 — REFUSAL PROCESSED BY IB
- 12 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER